Article
Characterizing Human Mesenchymal Stromal Cells Immune Modulatory Potency Using Targeted Lipidomic Profiling of Sphingolipids
2021-06-02
Abstract excerpt
<h4>ABSTRACT</h4> Cell therapies are expected to increase over the next decade due to increasing demand for clinical applications. Mesenchymal stromal cells (MSCs) have been explored to treat a number of diseases, with some successes in early clinical trials. Despite early successes, poor MSC characterization results in lessened therapeutic capacity once in vivo . Here, we characterized bone–marrow (BM), adipose...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7d5500e8-fcf6-541f-baa9-e201a789df12
- DOI
- 10.1101/2021.06.01.446428
